Vidwan-ID : 65766



  • Dr Siva Sundara Kumar Durairajan

  • Associate Professor
  • Central University of Tamil Nadu
Publications 2004 - 2024

Publications

  • 47
    Journal Articles
  • 4
    Book Chapter
  • 15
    Conference
    Proceedings
  • 8
    Review
  • 9
    Projects
  • 3
  • 2
  • 3

Citations / H-Index

2234 Citations
26 h-index
142 Citations

Altmetrics

76
44
110
1838
34

Google Scholar

Co-author Network


Expertise

Biology

Dr. D.Siva Sundara Kumar is presently an associate professor at the Department of Microbiology, Central University of Tamil Nadu, India. Prior to this he has served in the Hongkong Baptist University, Hong Kong as Research Assistant Professor (2012-2017). He has been involved with teaching and research activities in the area of Microbiology, Molecular Cell biology, Fungal Biotechnology., Neurodegenerative diseases, Molecular Pharmacology & Drug Discovery etc.

Personal Information

Dr Siva Sundara Kumar Durairajan

Male
Department of Mcirobiology Central University of Tamilnadu, Neelakudi
, Tamil Nadu, India - 610005


Experience

  • Associate Professor

    Department of Microbiology

    Central University of Tamil Nadu

  • Visiting Scientist

    School of Chinese Medicine

    Hong Kong Baptist University

  • Assistant Professor (Grade-II)

    Microbiology

    Hong Kong Baptist University

  • Senior Research Associate

    School of Chinese Medicine

    Hong Kong Baptist University

  • Post-Doctoral Research Scientist

    School of Chinese Medicine

    Hong Kong Baptist University

  • Post-Doctoral Fellow

    Vaccine R&D Center

    National Health Research Institutes, Taiwan


Qualification

  • PhD

    The University of Hong Kong

  • M.Tech

    Indian Institute of Technology Kharagpur

  • M.Sc.

    University of Madras

  • B.Sc

    Loyola College Chennai


Research Projects

Virtual and in vitro screening of spiropyrrolidine derivatives and DiversetTM core library small molecules to identify SARS-CoV-2 entry

Funding Agency : Department of Biotechnology, Government of India

Deciphering the role of Kinesin I heavy chain on the Tau phosphorylation and aggregation in Alzheimer

Funding Agency : SERB-DST Goverment of India

Investigation of Anti- Alzheimer's activity of Protopine derivative for clearing Tau through modulation of HDAC6- Hsp90 interplay and for improving memory via stimulation of RAS-GRF1/ERK pathway

Funding Agency : Health and Medical Research Fund

Read More

Virtual and in vitro screening of spiropyrrolidine derivatives and DiversetTM core library small molecules to identify SARS-CoV-2 entry

Funding Agency : Department of Biotechnology, Government of India

Deciphering the role of Kinesin I heavy chain on the Tau phosphorylation and aggregation in Alzheimer

Funding Agency : SERB-DST Goverment of India

Investigation of Anti- Alzheimer's activity of Protopine derivative for clearing Tau through modulation of HDAC6- Hsp90 interplay and for improving memory via stimulation of RAS-GRF1/ERK pathway

Funding Agency : Health and Medical Research Fund

Alzheimer's Disease: From Detection

Funding Agency : Research Grant Commission, Goverment of Hong Kong

Potential repositioning of antiepileptic drugs for the treatment of Alzheimer

Funding Agency : Health and Medical Research Fund, Government of Hong Kong

Development of NeuroDefend: A traditional Chinese medicine formula optimized for treating Alzheimer’s disease and other tauopathies

Funding Agency : Innovation Technology Fund, Government of Hong Kong

Neuropharmacological and Chemical-genetical Approaches to Investigate the Therapeutic Effects of Yuanhu Zhitong Prescription in Treating Alzheimer

Funding Agency : Health and Medical Research Fund, Government of Hong Kong

An In Vivo Investigation of The Therapeutic Effects of Modified Huang-Lian-Jie-Du-Tang and Its Combination with a Western Drug memantin

Funding Agency : Health and Medical Research Fund, Government of Hong Kong

Structural modification of protopine alkaloid from the Chinese herbal medicine Yanhusuo for the optimization of anti-Alzheimer's disease activity

Funding Agency : Innovation Technology Fund, Government of Hong Kong

Read Less

Patents




Read More





Read Less